glp-1 receptor agonist structure Sweet Success: Crystal of the full-length bound to a peptide A small-molecule oral agonist of

Apperloo EM, Neuen BL, Fletcher RA, Jongs N, Anker SD, Bhatt DL, Butler J, Cherney DZI, Herrington WG, Inzucchi SE, Jardine MJ, Liu CC, Mahaffey KW, McGuire DK, McMurray JJV, Neal B, Packer M, Perkovic V, Sabatine MS, Solomon SD, Staplin N, Szarek M, Vaduganathan M, Wanner C, Wheeler DC, Wiviott SD, Zannad F, Heerspink HJL

Compounded medications are still available for specific patients if the treating physician has recommended a compounded medication that is not commercially available to meet a particular patients needs

& Chaiyakunapruk, N

Clinicians should exercise caution until larger, carefully planned prospective trials elucidate these correlations, particularly when administering GLP-1 RAs for prolonged periods of time in individuals that are already at risk for colorectal cancers

Psychiatry 9, 784